K200801 is an FDA 510(k) clearance for the Quantisal Oral Fluid Collection Device. Classified as Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device (product code PJD), Class II - Special Controls.
Submitted by Immunalysis Corporation (Pomona, US). The FDA issued a Cleared decision on July 28, 2020 after a review of 123 days - within the typical 510(k) review window.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1675 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.
View all Immunalysis Corporation devices